Plastic-Associated Endocrine Disruptors Pose a New Metabolic Threat in Diabetes Care
Personalized briefing
Discovery of the day · Diabetes
Plasticizing Diabetes Care: The Metabolic Threat of Plastic-Associated Endocrine Disruptors and Micro-/Nanoplastics in Clinical Medicine
Dear Dr. Vijay Viswanathan, this is your personalized scientific intelligence briefing — curated for your work in Diabetes.
Key finding
Medicine · Diabetes
Discovery of the day
This review synthesizes emerging evidence that plastic-associated endocrine-disrupting chemicals and micro-/nanoplastics present in clinical medical devices and the environment may impair glucose metabolism, insulin sensitivity, and β-cell function. The authors demonstrate that these contaminants can interfere with hormone signaling pathways, contributing to metabolic dysregulation that complicates diabetes management. For a clinical diabetologist leading care at a major institution like MV Hospital, this finding underscores the need to consider environmental exposures—potentially from diabetes care supplies such as insulin pump tubing or IV sets—as modifiable risk factors that may influence treatment outcomes and complication rates in patients.
Novelty
88%
Rigor
75%
Significance
82%
Validity
70%
Clarity
90%
Advertisement
ScientificChina — The Global Marketplace for Scientific and Medical Equipments Start Browsing →
Your briefing is personalized based on your selected fields, keywords, and research interests.
